SCHEMBL9825638

SCHEMBL9825638

CCSC1=NOC(CNC(=O)[C@H](CCC(=O)O)NC(=O)OCc2ccccc2)C1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 7/20 0.57
CTSL P07711 2/20 0.46
CTSS P25774 2/20 0.46
CYP1A2 P05177 1/20 0.45
BCHE P06276 2/20 0.44
ACHE P22303 2/20 0.44
CACNA1F O60840 1/20 0.44
CACNA1D Q01668 1/20 0.44
CACNA1S Q13698 1/20 0.44
CACNA1C Q13936 1/20 0.44
ITGB3 P05106 5/20 0.43
ITGAV P06756 5/20 0.43
SIRT1 Q96EB6 1/20 0.42
CTSB P07858 1/20 0.42
CTSK P43235 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ITGA2B P08514 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9825943 0.93 TGM2 (0.59) TGM2CTSLCTSSCYP1A2ITGB3
SCHEMBL9826397 0.91 TGM2 (0.69) TGM2CTSLCTSSCYP1A2CTSB
SCHEMBL9825336 0.91 TGM2 (0.69) TGM2CTSLCTSSCYP1A2CTSB
SCHEMBL9825517 0.87 TGM2 (0.75) TGM2CTSLCTSSCTSBCTSK
SCHEMBL9826660 0.87 TGM2 (0.49) TGM2ITGB3ITGAVITGA2B
SCHEMBL9825279 0.86 TGM2 (0.63) TGM2CTSLCTSSCYP1A2CTSB
SCHEMBL9827308 0.86 TGM2 (0.63) TGM2CTSLCTSSCYP1A2CTSB
SCHEMBL9826986 0.86 TGM2 (0.66) TGM2CTSLCTSSCTSBCTSK
SCHEMBL9825257 0.86 TGM2 (0.61) TGM2CTSLCTSSCYP1A2CTSB
SCHEMBL9826332 0.86 TGM2 (0.75) TGM2CTSLCTSSCYP1A2ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0237082-B1 3,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOLES AS TRANSGLUTAMINASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1991-05-29 EP disclosed
US-4912120-A Containing amine and amide substitution SYNTEX (U.S.A.) INC. (US) 1990-03-27 US disclosed
EP-0237082-A2 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors SYNTEX (U.S.A.) INC. (US) 1987-09-16 EP disclosed